BCS Private Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$868K Buy
6,712
+25
+0.4% +$2.93K 0.26% 67
2026
Q1
$810K Buy
6,687
+45
+0.7% +$5.2K 0.25% 79
2025
Q4
$705K Buy
6,642
+1,675
+34% +$157K 0.24% 73
2025
Q3
$417K Buy
4,967
+2,239
+82% +$184K 0.15% 107
2025
Q2
$218K Buy
+2,728
New +$217K 0.08% 160

Other funds holding MRK

BCS Private Wealth Management's MRK Position: Q2 2026 in Review

BCS Private Wealth Management increased its Merck (MRK) stake by 0.37% in Q2 2026, buying an estimated $2.93K and bringing the position to 6,712 shares worth $868K. The position accounts for 0.26% of the portfolio, ranked #67.

BCS Private Wealth Management first reported a position in MRK in Q2 2025 and has held it in 5 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • BCS Private Wealth Management held 6,712 shares of Merck worth $868K as of Q2 2026.
  • BCS Private Wealth Management bought 25 Merck shares in Q2 2026, an estimated $2.93K.
  • Merck made up 0.26% of BCS Private Wealth Management's portfolio in Q2 2026, its #67 holding.
  • BCS Private Wealth Management first reported a position in Merck in Q2 2025 and has held it in 5 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on BCS Private Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.